AST SpaceMobile Joins MSCI ACWI Index as Largest New Addition, Boosting Market Visibility 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Samsung Electronics Sees Sustained AI-Driven Demand for Memory Chips Into Next Year 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
ByteDance Advances AI Chip Development With Samsung Manufacturing Talks 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
xAI Co-Founder Jimmy Ba Departs as Elon Musk’s AI Startup Faces Turbulence 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
FDA Rejects Review of Moderna’s Flu Vaccine Application, Shares Slide 
WASHINGTON, D.C., March 13, 2018 -- In a new story for Inside Science News Service, Joel Shurkin offers an intimate look at why Alzheimer's research is failing to help patients, including his own wife. Inside Science is an editorially-independent nonprofit journalism venture operated by the American Institute of Physics.
Researchers have long believed that Alzheimer's disease symptoms are caused by protein deposits called "amyloid plaques." But the amyloid model may be wrong, writes Shurkin, and that could explain why so many new drugs have failed in clinical trials. Shurkin's wife was a patient in a now-canceled trial, and her story offers a poignant glimpse of the human cost of such failures.
Shurkin explains the science that led to the amyloid model, as well as the creeping doubts now rising amongst Alzheimer's researchers. He goes on to describe potential new directions for future research -- research that will be too late for his wife, but perhaps life-saving for others down the road.
####
ABOUT INSIDE SCIENCE
Inside Science is an editorially-independent nonprofit science news service run out of the American Institute of Physics and supported by a coalition of underwriters. It produces original breaking news stories, features, essays, illustrations, documentaries, animations and news videos, all of which are procurable for syndication by news organizations or available on our web site. https://www.insidescience.org
ABOUT AIP
The American Institute of Physics is an organization of physical science societies, representing scientists, engineers, educators, and students. AIP delivers valuable services and expertise in education and student programs, science communications, government relations, career
AIP Media American Institute of Physics 301-209-3090 [email protected]
